S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

HUGE FSD Pharma Inc

0.1599

-0.0101 (-5.94%)

29 Jun 2024 - Closed

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

nullnull

FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more FSD Pharma Charts.

FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more FSD Pharma Charts.

FSD Pharma Inc News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 13 June 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (4 months ago) • Edgar (US Regulatory)

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
Friday 12 January 2024 (6 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Friday 5 January 2024 (6 months ago) • Edgar (US Regulatory)

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
Friday 22 September 2023 (9 months ago) • GlobeNewswire Inc.

FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
Saturday 26 August 2023 (10 months ago) • Business Wire

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Thursday 3 August 2023 (11 months ago) • GlobeNewswire Inc.

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
Tuesday 18 July 2023 (11 months ago) • Business Wire

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Monday 10 July 2023 (12 months ago) • Business Wire

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Wednesday 5 July 2023 (12 months ago) • Business Wire

More FSD Pharma Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions